US: 800.298.5699
Int'l: +1.240.747.3093
 
Matching geography
Reports matching your search in:
 
 
Join Alert Me now!
Receive bi-weekly email alerts on new market research

Sign up today!
 

Biotechnology Company Reports Market Research Reports & Industry Analysis

RSS Feeds

Biotechnology Company Reports Industry Research & Market Reports

< prev 1    3  4  5  6  7  8  9  10  
Alkermes Plc - Product Pipeline Review - 2014
10/25/2014 | published by: Global Markets Direct
... provides comprehensive information on the current therapeutic developmental pipeline of Alkermes Plc’s, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. ...  |  read more...
USD 1,500
Albany Molecular Research, Inc. (AMRI) - Financial and Strategic SWOT Analysis Review
10/15/2014 | published by: GlobalData
... bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you ...  |  read more...
USD 250
Kuros Biosurgery AG - Product Pipeline Analysis, 2014 Update
10/27/2014 | published by: GlobalData
... improve mesh grafting in burns patients, KUR-213 for abdominoplasty, and KUR-023 as synthetic dural sealant. Kuros offers KUR-111 for tibial plateau fractures, KUR-112 for solitary bone cysts, and KUR-113 for tibial shaft fractures. The company ...  |  read more...
USD 1,500
Lonza Group Ltd (LONN) - Financial and Strategic SWOT Analysis Review
10/21/2014 | published by: GlobalData
... to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to ...  |  read more...
USD 250
TheraDiag SA - Product Pipeline Analysis, 2014 Update
10/17/2014 | published by: GlobalData
... system for treatment of autoimmune diseases by anti-TNFa. The company offers services in the autoimmune disease diagnostic market. It develops and offers product panels for diagnosing autoimmune diseases, allergies, and infectious diseases. The company offers ...  |  read more...
USD 1,500
Pieris AG - Product Pipeline Review - 2014
10/25/2014 | published by: Global Markets Direct
... provides comprehensive information on the current therapeutic developmental pipeline of Pieris AG’s, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. ...  |  read more...
USD 1,500
Eqalix, Inc. - Product Pipeline Analysis, 2014 Update
10/17/2014 | published by: GlobalData
... wound dressing is used for wounds from pressure, venous and chronic vascular ulcers, diabetes, trauma and surgery, second degree burns and other partial and full thickness wounds. The company’s product line extension also includes temporary ...  |  read more...
USD 1,500
Seattle Genetics, Inc. (SGEN) - Financial and Strategic SWOT Analysis Review
10/21/2014 | published by: GlobalData
... to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to ...  |  read more...
USD 250
Five Prime Therapeutics, Inc. - Product Pipeline Review - 2014
9/22/2014 | published by: Global Markets Direct
... research and development focus. This report provides comprehensive information on the current therapeutic developmental pipeline of Five Prime Therapeutics, Inc.’s, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action ...  |  read more...
USD 1,500
Nuclea Biotechnologies Inc. - Product Pipeline Analysis, 2014 Update
9/18/2014 | published by: GlobalData
... colon, stomach, leukemia, lung and prostate. Nuclea utilizes its proprietary DecisionDx platform in the development of in vitro companion diagnostics for use in therapeutic and medical imaging applications. It conducts research on novel molecular oncology ...  |  read more...
USD 750
OncoSec Medical Inc. (ONCS) - Product Pipeline Analysis, 2014 Update
9/18/2014 | published by: GlobalData
... two kinds of tests to eradicate various kinds of cancers such as ImmunoPulse and NeoPulse. OncoSec’S ImmunoPulse is used to treat metastatic cancers. The company’s NeoPulse is used to treat primary and recurrent cancers that ...  |  read more...
USD 750
Celgene Corporation - Strategy and SWOT Report
10/7/2014 | published by: MarketLine
... a 360° view of the company. Features: Detailed information on Celgene Corporation required for business and competitor intelligence needs A study of the major internal and external factors affecting Celgene Corporation in the form of ...  |  read more...
USD 175
Celera Group - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report
9/22/2014 | published by: MarketLine
... Project Description: MarketLines' Celera Group Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), divestments, capital raisings, venture capital investments, ownership and partnership transactions ...  |  read more...
USD 350
WaferGen Bio-systems, Inc - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report
9/22/2014 | published by: MarketLine
... Project Description: MarketLines' WaferGen Bio-systems, Inc Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), divestments, capital raisings, venture capital investments, ownership and partnership ...  |  read more...
USD 350
Genetic Technologies Limited - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report
9/22/2014 | published by: MarketLine
... Project Description: MarketLines' Genetic Technologies Limited Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), divestments, capital raisings, venture capital investments, ownership and partnership ...  |  read more...
USD 350
Lonza Group, Ltd. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report
9/22/2014 | published by: MarketLine
... Project Description: MarketLines' Lonza Group, Ltd. Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), divestments, capital raisings, venture capital investments, ownership and partnership ...  |  read more...
USD 350
International Stem Cell Corporation - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report
9/22/2014 | published by: MarketLine
... Project Description: MarketLines' International Stem Cell Corporation Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), divestments, capital raisings, venture capital investments, ownership and ...  |  read more...
USD 350
Oxygen Biotherapeutics, Inc. (formerly Synthetic Blood International, Inc.) - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report
9/22/2014 | published by: MarketLine
... Project Description: MarketLines' Oxygen Biotherapeutics, Inc. (formerly Synthetic Blood International, Inc.) Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), divestments, capital raisings, venture ...  |  read more...
USD 350
Bayer MaterialScience AG - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report
9/22/2014 | published by: MarketLine
... Project Description: MarketLines' Bayer MaterialScience AG Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), divestments, capital raisings, venture capital investments, ownership and partnership ...  |  read more...
USD 350
Genentech, Inc. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report
9/22/2014 | published by: MarketLine
... Project Description: MarketLines' Genentech, Inc. Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), divestments, capital raisings, venture capital investments, ownership and partnership transactions ...  |  read more...
USD 350
Generex Biotechnology Corporation - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report
9/22/2014 | published by: MarketLine
... Project Description: MarketLines' Generex Biotechnology Corporation Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), divestments, capital raisings, venture capital investments, ownership and partnership ...  |  read more...
USD 350
Genmab A/S - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report
9/22/2014 | published by: MarketLine
... Project Description: MarketLines' Genmab A/S Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), divestments, capital raisings, venture capital investments, ownership and partnership transactions ...  |  read more...
USD 350
Verenium Corporation (Formerly Diversa Corporation) - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report
9/22/2014 | published by: MarketLine
... Project Description: MarketLines' Verenium Corporation (Formerly Diversa Corporation) Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), divestments, capital raisings, venture capital investments, ownership ...  |  read more...
USD 350
Celgene Corporation - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report
9/22/2014 | published by: MarketLine
... Project Description: MarketLines' Celgene Corporation Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), divestments, capital raisings, venture capital investments, ownership and partnership transactions ...  |  read more...
USD 350
Micromet, Inc. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report
9/22/2014 | published by: MarketLine
... Project Description: MarketLines' Micromet, Inc. Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), divestments, capital raisings, venture capital investments, ownership and partnership transactions ...  |  read more...
USD 350
< prev 1    3  4  5  6  7  8  9  10